These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30738484)

  • 21. [Mesenchymal stem cells for treatment of graft-versus-host disease].
    Najima Y
    Rinsho Ketsueki; 2017; 58(12):2440-2449. PubMed ID: 29332881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality Control Analysis of Mesenchymal Stem/Stromal Cells During Investigational New Drug Application for GvHD Administration in China.
    Wang A; Zhang L; Zhao M; Yu H
    Curr Stem Cell Res Ther; 2023; 18(8):1032-1040. PubMed ID: 35619293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease.
    Fan X; Guo D; Cheung AMS; Poon ZY; Yap CS; Goh SE; Guo D; Li H; Bari S; Li S; Lim KH; Hwang WYK
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):1971-1980. PubMed ID: 29883796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic Stem Cell Transplantation with Mesenchymal Stromal Cells in Children with Metachromatic Leukodystrophy.
    Cabanillas Stanchi KM; Böhringer J; Strölin M; Groeschel S; Lenglinger K; Treuner C; Kehrer C; Laugwitz L; Bevot A; Kaiser N; Schumm M; Lang P; Handgretinger R; Krägeloh-Mann I; Müller I; Döring M
    Stem Cells Dev; 2022 Apr; 31(7-8):163-175. PubMed ID: 35323019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of the application of mesenchymal stem cells in the field of hematopoietic stem cell transplantation.
    Lin T; Yang Y; Chen X
    Eur J Med Res; 2023 Aug; 28(1):268. PubMed ID: 37550742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipose tissue-derived mesenchymal stem cells ameliorate bone marrow aplasia related with graft-versus-host disease in experimental murine models.
    Nishi Y; Murakami A; Murayama Y; Tsukahara N; Okamoto S; Nakachi S; Morichika K; Tamaki K; Noguchi H; Matsushita M; Karube KN; Fukushima T; Morishima S; Kishimoto H; Masuzaki H
    Transpl Immunol; 2019 Aug; 55():101205. PubMed ID: 30946889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation.
    Zhao K; Liu Q
    J Hematol Oncol; 2016 May; 9(1):46. PubMed ID: 27193054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.
    Xiong YY; Fan Q; Huang F; Zhang Y; Wang Y; Chen XY; Fan ZP; Zhou HS; Xiao Y; Xu XJ; Dai M; Xu N; Sun J; Xiang P; Huang XJ; Liu QF
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):236-42. PubMed ID: 24216182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Toubai T; Paczesny S; Shono Y; Tanaka J; Lowler KP; Malter CT; Kasai M; Imamura M
    Curr Stem Cell Res Ther; 2009 Dec; 4(4):252-9. PubMed ID: 19500066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice.
    Kim N; Im KI; Lim JY; Jeon EJ; Nam YS; Kim EJ; Cho SG
    Ann Hematol; 2013 Oct; 92(10):1295-308. PubMed ID: 23722500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
    Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
    Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the immunomodulatory effect of single MSC batches versus pooled MSC products.
    Hejretová L; Čedíková M; Dolejšová M; Vlas T; Jindra P; Lysák D; Holubová M
    Cell Tissue Bank; 2020 Mar; 21(1):119-129. PubMed ID: 31863261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity.
    Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK
    Biol Blood Marrow Transplant; 2015 May; 21(5):934-40. PubMed ID: 25659882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stromal cells and hematopoietic stem cell transplantation.
    Bernardo ME; Fibbe WE
    Immunol Lett; 2015 Dec; 168(2):215-21. PubMed ID: 26116911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the treatment of graft-versus-host disease with immunomodulatory cells.
    Yu Q; Wang H; Zhang L; Wei W
    Int Immunopharmacol; 2021 Mar; 92():107349. PubMed ID: 33486323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stem cell-derived exosomes for managing graft-versus-host disease: An updated view.
    Shafeghat Z; Dorfaki M; Dehrouyeh S; Arab FL; Roozbehani M; Falak R; Faraji F; Jafari R
    Transpl Immunol; 2023 Dec; 81():101957. PubMed ID: 37935319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of therapeutic role of mesenchymal stromal cells in mouse models of graft-versus-host disease using cryo-imaging.
    Wuttisarnwattana P; Eid S; Wilson DL; Cooke KR
    Sci Rep; 2023 Jan; 13(1):1698. PubMed ID: 36717650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation.
    Kim EJ; Kim N; Cho SG
    Exp Mol Med; 2013 Jan; 45(1):e2. PubMed ID: 23306700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.